S. Kim

Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge

Soo‐Young Yoon, So Yeon Park, S. Kim et al. · Allergy · 2013 · 60 citations

The highest prognostic impact of LDH among International Prognostic Indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab

Jin‐hong Park, Dok Hyun Yoon, Dalyong Kim et al. · Annals of Hematology · 2014 · 46 citations

Disease Progression, Ipi Factors, Medicine +7

Aspiration: First-Line Erlotinib (E) Until and Beyond Recist Progression (Pd) in Asian Patients (Pts) with Egfr Mutation-Positive (Mut+) Nsclc

K. Park, Myung‐Ju Ahn, Chong‐Jen Yu et al. · Annals of Oncology · 2014 · 39 citations

Beyond Recist Progression, Medicine, First-line Erlotinib +8

OA 09.03 TATTON Ph Ib Expansion Cohort: Osimertinib plus Savolitinib for Pts with EGFR-Mutant MET-Amplified NSCLC after Progression on Prior EGFR-TKI

Myung‐Ju Ahn, Ji‐Youn Han, Lecia V. Sequist et al. · Journal of Thoracic Oncology · 2017 · 35 citations · Full text

Oncology, Medicine, Pharmacology +8

OA 05.07 Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC

Byoung Chul Cho, Radka Obermannová, Alessandra Bearz et al. · Journal of Thoracic Oncology · 2017 · 10 citations

Alk+ Metastatic Nsclc, Oncology, Metronomic Therapy +7